Company / Operating Income per Share
Corvus Pharmaceuticals, Inc. Operating Income per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.45
FY2024
5-year range
-$1.48 / -$0.45
FY2020-FY2024
Trend
+7.3%
vs FY2023
Sector context
#71 of 199
Health Care
What the data says
At $-0.45, Corvus Pharmaceuticals, Inc.'s operating income per share ranks #71 of 199 in the Health Care sector. Operating Income per Share has increased for 7 consecutive years, from $-2.76 in FY2017 to $-0.45 in FY2024.
Based on SEC 10-K filings.
-0.45 in FY2024.
Improved from $-0.70 to $-0.45 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#71 of 199 in Health CareTop 36% of 199This company -$0.45 Sector average -$3.34
▼
+86.5% above sector average
Key checks
Key Insights
- Corvus Pharmaceuticals, Inc.'s operating income per share has grown for 7 consecutive years.
- In FY2024, operating income per share increased 7.3% year-over-year.
- Ranks #71 out of 199 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.45 | +7.3% |
| FY2023 | -$0.49 | +30.3% |
| FY2022 | -$0.70 | +24.2% |
| FY2021 | -$0.92 | +37.8% |
| FY2020 | -$1.48 | +10.8% |
| FY2019 | -$1.66 | +7.0% |
| FY2018 | -$1.79 | +35.1% |
| FY2017 | -$2.76 | -15.1% |
| FY2016 | -$2.40 | +93.5% |
| FY2015 | -$36.85 | -3797.7% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026